News
-
-
PRESS RELEASE
HBM Healthcare Investments publishes Quarterly Report as at 31 December 2024 with key figures for the first nine months of the 2024/2025 financial year
HBM Healthcare Investments reports a profit of CHF 66 million in the first nine months of the 2024/2025 financial year, driven by private portfolio companies. NAV up 4.3%, share price down 5.2% -
-
-
-
-
-
-
-
PRESS RELEASE
Successful IPO of HBM portfolio company Sai Life Sciences on the Indian stock exchanges NSE and BSE increases NAV per HBM share by 3.2 percent
HBM Healthcare Investments' portfolio company Sai Life Sciences has a successful IPO on Indian stock exchanges, increasing NAV per HBM share by 3.2%
